4Tawara S,Ikeda F,Maki K,et al.In vitro activities of a new lipopeptide antifungal agent micafungin against a variety of clinically important fungi[J].Antimicrob Agents Chemother,2000,44(1):57. 被引量：1
9Mary F H,Pharm D,Helen E S,et al.Pharmacokinetics of Micafuungin in healthy volunteers,volunteers with modertate liver disease,and volunteers with renal dysfunction[J].J Clin Pharmacol,2005,45:1145. 被引量：1
6New Guidelines on Anaemia Management in Patients with Cancer:How Do These Affect Clinical Practice [ J ] ? Gunnar Birgegarda,Carsten Bokemeyerb. a Department of Hematology, University Hospital, Uppsala, Sweden; bUniversity Medical Center, Eppendorf, Department of Haematology and Oncology, Hamburg,Germany, Oncology, 2005, 69 (Suppl2): 17-21. 被引量：1
7Practice HG, Kibbler CC, Prentice AG. Towards a targeted,risk -based, antifungal strategy in neutropenic patients [ J ]. Br J Haematol, 2003, 110:273-284. 被引量：1
8Becker M J, Lugtenburg E J, Coruelissen J J, et al. Galactomannan detection in computerized tomography - based broncho - alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis [ J ] . Br J Haematol, 2003,121 : 448 -457. 被引量：1
9Maertens J, Van Eldere J, Verhaegen J, et al. Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients [J]. J Infect Dis, 2002, 186: 1297-1306. 被引量：1
10Menichetti F, Favero AD, Martino P, et al. Traconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo - controlled, double - blind, multicenter trial [ J ]. Clinical Infectious Diseases, 1999, 28, 250-255. 被引量：1
